These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2925242)
1. Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model. Greenberg DP; Bayer AS; Cheung AL; Ward JI Infect Immun; 1989 Apr; 57(4):1113-8. PubMed ID: 2925242 [TBL] [Abstract][Full Text] [Related]
2. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassays for protein A of Staphylococcus aureus. Langone JJ; Das C; Bennett D; Terman DS J Immunol Methods; 1983 Oct; 63(2):145-57. PubMed ID: 6619552 [TBL] [Abstract][Full Text] [Related]
4. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus. Rozalska B; Wadström T Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103 [TBL] [Abstract][Full Text] [Related]
5. Antibody responses to protein A in patients with Staphylococcus aureus bacteremia and endocarditis. Greenberg DP; Bayer AS; Turner D; Ward JI J Clin Microbiol; 1990 Mar; 28(3):458-62. PubMed ID: 2324274 [TBL] [Abstract][Full Text] [Related]
6. Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice. Kim HK; Emolo C; DeDent AC; Falugi F; Missiakas DM; Schneewind O Infect Immun; 2012 Oct; 80(10):3460-70. PubMed ID: 22825452 [TBL] [Abstract][Full Text] [Related]
7. Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus. Thammavongsa V; Rauch S; Kim HK; Missiakas DM; Schneewind O Vaccine; 2015 Jan; 33(4):523-6. PubMed ID: 25488332 [TBL] [Abstract][Full Text] [Related]
8. Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Palmqvist N; Silverman GJ; Josefsson E; Tarkowski A Microbes Infect; 2005 Dec; 7(15):1501-11. PubMed ID: 16039897 [TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Lee JC; Park JS; Shepherd SE; Carey V; Fattom A Infect Immun; 1997 Oct; 65(10):4146-51. PubMed ID: 9317020 [TBL] [Abstract][Full Text] [Related]
10. A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia. Varshney AK; Kuzmicheva GA; Lin J; Sunley KM; Bowling RA; Kwan TY; Mays HR; Rambhadran A; Zhang Y; Martin RL; Cavalier MC; Simard J; Shivaswamy S PLoS One; 2018; 13(1):e0190537. PubMed ID: 29364906 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144 [TBL] [Abstract][Full Text] [Related]
12. Protein A-Mediated Binding of Cronin UP; Girardeaux L; O'Meara E; Wilkinson MG Appl Environ Microbiol; 2020 Aug; 86(17):. PubMed ID: 32591386 [No Abstract] [Full Text] [Related]
13. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Nanra JS; Buitrago SM; Crawford S; Ng J; Fink PS; Hawkins J; Scully IL; McNeil LK; Aste-Amézaga JM; Cooper D; Jansen KU; Anderson AS Hum Vaccin Immunother; 2013 Mar; 9(3):480-7. PubMed ID: 23249887 [TBL] [Abstract][Full Text] [Related]
14. Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup. Sasso EH; Silverman GJ; Mannik M J Immunol; 1991 Sep; 147(6):1877-83. PubMed ID: 1909733 [TBL] [Abstract][Full Text] [Related]
15. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Maira-Litrán T; Kropec A; Goldmann DA; Pier GB Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353 [TBL] [Abstract][Full Text] [Related]
16. A novel bivalent fusion vaccine induces broad immunoprotection against Staphylococcus aureus infection in different murine models. Yang L; Zhou H; Cheng P; Yang Y; Tong Y; Zuo Q; Feng Q; Zou Q; Zeng H Clin Immunol; 2018 Mar; 188():85-93. PubMed ID: 29289748 [TBL] [Abstract][Full Text] [Related]
17. Peptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infection. Kim HK; Falugi F; Missiakas DM; Schneewind O Proc Natl Acad Sci U S A; 2016 May; 113(20):5718-23. PubMed ID: 27140614 [TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine. Zhang F; Jun M; Ledue O; Herd M; Malley R; Lu YJ Vaccine; 2017 Jul; 35(31):3834-3843. PubMed ID: 28601365 [TBL] [Abstract][Full Text] [Related]
19. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection. Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725 [TBL] [Abstract][Full Text] [Related]
20. The characterization of antibacterial antibodies in bovine immune sera to Staphylococcus aureus. Yokomizo Y; Isayama Y Microbiol Immunol; 1978; 22(1):1-13. PubMed ID: 661625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]